drugset / Trial / NCT06103227

The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth

NCT06103227

Phase 2/3 Completed 26 enrolled University of Mostar
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to test the effect of a low dose of prednisone in the prevention of preterm labour in singleton pregnancies. The main question it aims to answer is whether prednisone prolongs singleton pregnancy in threatened preterm birth and reduces mortality and morbidity of newborns without harmful consequences for the mother and the foetus. Participants will be: * administered low dose of prednisone in a period of a total of 3 weeks on top of standard therapy * drown blood for standard laboratory tests * cervical swab and urine for urine culture will be taken, and * asked to sign Informed Consent The researcher will compare a low dose of prednisone to standard therapy.

Timeline

Start
2023-11-08
Primary completion
2024-11-25
Completion
2024-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 5 mg

Indications

No indication recorded.